A Study to Investigate Mocertatug Rezetecan With Bevacizumab Compared With Platinum Doublet With Bevacizumab in Participants With Platinum-sensitive Ovarian Cancer (BEHOLD-Ovarian02)

Clinical trial NCT07684612 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07684612
Sponsor: GlaxoSmithKline
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Ovarian Neoplasms

Start date: 2026-09-22
Primary completion: 2030-05-21
Enrollment: 690

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.